Korro Bio

Korro Bio Leads the New Field of RNA Therapeutics. Its Proprietary Platform OPERA (Oligonucleotide-Promoted RNA Editing) Utilizes the Human Body's Own RNA Editing System to Precisely Edit a Single Base. Korro’s Therapeutic Approach Uses Synthetic Oligonucleotides to Repair Disease-Causing Mutations at the RNA Level. This Method Can Also Be Used to Create Therapeutically Beneficial Versions of Proteins to Improve Patient Outcomes. Korro’s Programs Target a Range of Innovative RNA Editing Therapies for the Liver, Eyes, and Central Nervous System.